Literature DB >> 24338746

Comparison of sensitivity and specificity among 15 criteria for chronic inflammatory demyelinating polyneuropathy.

Ari Breiner1, Thomas H Brannagan.   

Abstract

INTRODUCTION: There have been 15 formal sets of criteria published for the diagnosis of CIDP. No study to date has compared the sensitivity and specificity of all published criteria in the same patient population.
METHODS: We conducted a retrospective chart review of patients with CIDP (n = 56) and controls with diabetic polyneuropathy (n = 37) or amyotrophic lateral sclerosis (n = 39) who were followed in an academic neuromuscular practice. The sensitivity and specificity of each CIDP criterion was calculated, including clinical, laboratory, and electrodiagnostic components.
RESULTS: Sensitivities ranged from 1.8% to 87.5%; the Dyck (87.5%), Neuropathy Association (75%), and European Federation of Neurological Societies (EFNS; 73.2%) criteria ranked highest. Specificities ranged from 65.6% to 100% and, among the 3 most sensitive criteria, the EFNS (90.8%) and Neuropathy Association (82.9%) criteria were most specific.
CONCLUSIONS: In our patient population, the EFNS and Neuropathy Association criteria stand out due to high sensitivity and specificity.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  CIDP; diagnostic criteria; neuropathy; sensitivity; specificity

Mesh:

Year:  2013        PMID: 24338746     DOI: 10.1002/mus.24088

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  18 in total

Review 1.  Immune-mediated neuropathies.

Authors:  Bernd C Kieseier; Emily K Mathey; Claudia Sommer; Hans-Peter Hartung
Journal:  Nat Rev Dis Primers       Date:  2018-10-11       Impact factor: 52.329

2.  Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Five New Things.

Authors:  Chafic Karam
Journal:  Neurol Clin Pract       Date:  2022-06

3.  Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis.

Authors:  Merel C Broers; Carina Bunschoten; Daan Nieboer; Hester F Lingsma; Bart C Jacobs
Journal:  Neuroepidemiology       Date:  2019-01-22       Impact factor: 3.282

Review 4.  Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies.

Authors:  Johannes J Roggenbuck; Joseph Boucraut; Emilien Delmont; Karsten Conrad; Dirk Roggenbuck
Journal:  Ann Transl Med       Date:  2018-09

5.  Evaluation of the EFNS/PNS diagnostic criteria in a cohort of CIDP patients.

Authors:  Diamantis Athanasopoulos; Jeremias Motte; Thomas Grüter; Nuray Köse; Min-Suk Yoon; Susanne Otto; Christiane Schneider-Gold; Ralf Gold; Anna L Fisse; Kalliopi Pitarokoili
Journal:  Ann Clin Transl Neurol       Date:  2021-04-07       Impact factor: 4.511

Review 6.  Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Man Mohan Mehndiratta; Richard A C Hughes; Jane Pritchard
Journal:  Cochrane Database Syst Rev       Date:  2015-08-25

Review 7.  Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.

Authors:  Emily K Mathey; Susanna B Park; Richard A C Hughes; John D Pollard; Patricia J Armati; Michael H Barnett; Bruce V Taylor; P James B Dyck; Matthew C Kiernan; Cindy S-Y Lin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-02-12       Impact factor: 10.154

8.  Recurrence Quantification Analysis of F-Waves and the Evaluation of Neuropathies.

Authors:  Morris A Fisher; Vijaya K Patil; Charles L Webber
Journal:  Neurol Res Int       Date:  2015-11-24

9.  Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination.

Authors:  Alon Abraham; Majed Alabdali; Mohammad Qrimli; Hana Albulaihe; Ari Breiner; Carolina Barnett; Hans D Katzberg; Leif E Lovblom; Bruce A Perkins; Vera Bril
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

10.  Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy.

Authors:  Mark Stettner; Lena Hinrichs; Rainer Guthoff; Silja Bairov; Ioannis N Petropoulos; Clemens Warnke; Hans-Peter Hartung; Rayaz A Malik; Bernd C Kieseier
Journal:  Ann Clin Transl Neurol       Date:  2015-12-28       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.